Log in to save to my catalogue

Gamma delta T-cell-based immune checkpoint therapy: attractive candidate for antitumor treatment

Gamma delta T-cell-based immune checkpoint therapy: attractive candidate for antitumor treatment

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_72076c932fd64fe0a514a23f9f837e88

Gamma delta T-cell-based immune checkpoint therapy: attractive candidate for antitumor treatment

About this item

Full title

Gamma delta T-cell-based immune checkpoint therapy: attractive candidate for antitumor treatment

Publisher

England: BioMed Central Ltd

Journal title

Molecular cancer, 2023-02, Vol.22 (1), p.31-31, Article 31

Language

English

Formats

Publication information

Publisher

England: BioMed Central Ltd

More information

Scope and Contents

Contents

As a nontraditional T-cell subgroup, γδT cells have gained popularity in the field of immunotherapy in recent years. They have extraordinary antitumor potential and prospects for clinical application. Immune checkpoint inhibitors (ICIs), which are efficacious in tumor patients, have become pioneer drugs in the field of tumor immunotherapy since the...

Alternative Titles

Full title

Gamma delta T-cell-based immune checkpoint therapy: attractive candidate for antitumor treatment

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_doaj_primary_oai_doaj_org_article_72076c932fd64fe0a514a23f9f837e88

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_72076c932fd64fe0a514a23f9f837e88

Other Identifiers

ISSN

1476-4598

E-ISSN

1476-4598

DOI

10.1186/s12943-023-01722-0

How to access this item